A series of FC131 [cyclo(-d-Tyr-Arg-Arg-Nal-Gly-)] analogues containing amidine type peptide bond isosteres were synthesized as selective CXC chemokine receptor type 4 (CXCR4) antagonists. An isosteric amidine substructure was constructed by a macrocyclization process using nitrile oxide-mediated C-N bond formation. All of the amidine-containing FC131 analogues exhibited potent SDF-1 binding inhibition to CXCR4. The Nal-Gly-substituted analogue was characterized as one of the most potent cyclic pentapeptide-based CXCR4 antagonists reported to date. The improved activity against human immunodeficiency virus (HIV) type-1 X4 strains suggested that addition of another basic amidine group to the peptide backbone effectively increases the selective binding of the peptides to CXCR4 receptor.
A series of FC131 [n class="Chemical">cyclo(-d-Tyr-Arg-Arg-Nal-Gly-)] analogues containing amidine type peptide bond isosteres were synthesized as selective CXC chemokine receptor type 4 (CXCR4) antagonists. An isosteric amidine substructure was constructed by a macrocyclization process using nitrile oxide-mediated C-N bond formation. All of the amidine-containing FC131 analogues exhibited potent SDF-1 binding inhibition to CXCR4. The Nal-Gly-substituted analogue was characterized as one of the most potent cyclic pentapeptide-based CXCR4 antagonists reported to date. The improved activity against human immunodeficiency virus (HIV) type-1 X4 strains suggested that addition of another basic amidine group to the peptide backbone effectively increases the selective binding of the peptides to CXCR4 receptor.
Authors: Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens Journal: Science Date: 2010-10-07 Impact factor: 47.728
Authors: Gary J Bridger; Renato T Skerlj; Pedro E Hernandez-Abad; David E Bogucki; Zhongren Wang; Yuanxi Zhou; Susan Nan; Eva M Boehringer; Trevor Wilson; Jason Crawford; Markus Metz; Sigrid Hatse; Katrien Princen; Erik De Clercq; Dominique Schols Journal: J Med Chem Date: 2010-02-11 Impact factor: 7.446
Authors: Weiqiang Zhan; Zhongxing Liang; Aizhi Zhu; Serdar Kurtkaya; Hyunsuk Shim; James P Snyder; Dennis C Liotta Journal: J Med Chem Date: 2007-10-24 Impact factor: 7.446
Authors: G J Bridger; R T Skerlj; D Thornton; S Padmanabhan; S A Martellucci; G W Henson; M J Abrams; N Yamamoto; K De Vreese; R Pauwels Journal: J Med Chem Date: 1995-01-20 Impact factor: 7.446
Authors: B J Doranz; K Grovit-Ferbas; M P Sharron; S H Mao; M B Goetz; E S Daar; R W Doms; W A O'Brien Journal: J Exp Med Date: 1997-10-20 Impact factor: 14.307
Authors: Jian Xie; Akinori Okano; Joshua G Pierce; Robert C James; Simon Stamm; Christine M Crane; Dale L Boger Journal: J Am Chem Soc Date: 2012-01-06 Impact factor: 15.419
Authors: Antoinette G Nelson; Xiaoping Zhang; Usha Ganapathi; Zoltan Szekely; Charles W Flexner; Andrew Owen; Patrick J Sinko Journal: J Control Release Date: 2015-08-24 Impact factor: 9.776